Cerebrolysin

Cerebrolysin is a multi-modal neuropeptide medication produced by the biotechnological refinement of purified porcine (pig) brain proteins. It is composed of low-molecular-weight peptides and free amino acids that are small enough to cross the blood-brain barrier (BBB). Unlike many single-target drugs, Cerebrolysin contains a complex mixture of factors that mimic the activity of endogenous neurotrophic factors—natural substances in the body that promote the growth and survival of neurons. It is clinically utilized primarily in Europe and Asia for the treatment of ischemic and hemorrhagic stroke, traumatic brain injury (TBI), and various forms of dementia, including Alzheimer’s disease and vascular dementia.